Bongartz, T <br/><br/>
Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials.  [electronic resource] 

 -  Annals of the rheumatic diseases  Jul 2009 
 - 1177-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/ard.2008.094904  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Rheumatoid--drug therapy<br/>Etanercept<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Neoplasms--chemically induced<br/>Randomized Controlled Trials as Topic<br/>Receptors, Tumor Necrosis Factor<br/>Risk Assessment<br/>Risk Factors